MicroRNA profiling of pericardial fluid samples from patients with heart failure

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Kuosmanen, Suvi M ^a   Hartikainen, Juha ^a,b   Hippeläinen, Mikko ^b   Kokki, Hannu ^a,b   Levonen, Anna Liisa ^a   Tavi, Pasi ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; LET 7B 5P; MICRORNA; MICRORNA 125B 5P; MICRORNA 21 5P; MICRORNA 451A; MICRORNA16 5P; UNCLASSIFIED DRUG;

ADULT; AORTA STENOSIS; AORTA VALVE REGURGITATION; ARTICLE; CARDIAC STEM CELL; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE COURSE; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEART FAILURE; HEART FIBROBLAST; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MITRAL VALVE REGURGITATION; PARACRINE SIGNALING; PERICARDIAL EFFUSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; AGED; GENETICS; METABOLISM; PATHOLOGY; PROCEDURES; THORAX SURGERY;

AGED; FEMALE; GENE EXPRESSION PROFILING; HEART FAILURE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PERICARDIAL FLUID; THORACIC SURGICAL PROCEDURES;

EID: 84928911101     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119646     Document Type: Article

References (78)

1. Braunwald E. Heart Failure. JACC Heart Fail. 2013;1:1-20. doi: 10.1016/j.jchf.2012.10.002 PMID: 24621794
2. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62:e147-239. doi: 10. 1016/j.jacc.2013.05.019 PMID: 23747642
3. Gibson AT, Segal MB. A study of the composition of pericardial fluid, with special reference to the probable mechanism of fluid formation. J Physiol. 1978;277:367-77. PMID: 650542
4. Horkay F, Szokodi I, Selmeci L, Merkely B, Kékesi V, Vecsey T, et al. Presence of immunoreactive endothelin-1 and atrial natriuretic peptide in human pericardial fluid. Life Sci. 1998;62:267-74. PMID: 9488105
5. Watanabe M, Kawaguchi S, Nakahara H, Hachimaru T. The roles of natriuretic peptides in pericardial fluid in patients with heart failure. Clin Cardiol. 2009;32:159-63. doi: 10.1002/clc.20306 PMID: 19301292
6. Tambara K, Fujita M, Nagaya N, Miyamoto S, Iwakura A, Doi K, et al. Increased pericardial fluid concentrations of the mature form of adrenomedullin in patients with cardiac remodelling. Heart. 2002;87:242-6. PMID: 11847163
7. Abe N, Matsunaga T, Kameda K, Tomita H, Fujiwara T, Ishizaka H, et al. Increased level of pericardial insulin-like growth factor-1 in patients with left ventricular dysfunction and advanced heart failure. J Am Coll Cardiol. 2006;48:1387-95. PMID: 17010800
8. Selmeci L, Antal M, Horkay F, Merkely B, Szokodi I, Bíró L, et al. Enhanced accumulation of pericardial fluid ferritin in patients with coronary artery disease. Coron Artery Dis. 2000;11:53-6. PMID: 10715807
9. Fujita M, Komeda M, Hasegawa K, Kihara Y, Nohara R, Sasayama S. Pericardial fluid as a new material for clinical heart research. Int J Cardiol. 2001;77:113-8. PMID: 11182172
10. Corda S, Mebazaa A, Gandolfini MP, Fitting C, Marotte F, Peynet J, et al. Trophic effect of human pericardial fluid on adult cardiac myocytes. Differential role of fibroblast growth factor-2 and factors related to ventricular hypertrophy. CircRes. 1997;81:679-87. PMID: 9351441
11. Iwakura A, Fujita M, Hasegawa K, Sawamura T, Nohara R, Sasayama S, et al. Pericardial fluid from patients with unstable angina induces vascular endothelial cell apoptosis. J Am Coll Cardiol. 2000;35:1785-90. PMID: 10841225
12. Yoneda T, Fujita M, Kihara Y, Hasegawa K, Sawamura T, Tanaka T, et al. Pericardial fluid from patients with ischemic heart disease accelerates the growth of human vascular smooth muscle cells. Jpn Circ J. 2000;64:495-8. PMID: 10929776
13. Limana F, Bertolami C, Mangoni A, Di Carlo A, Avitabile D, Mocini D, et al. Myocardial infarction induces embryonic reprogramming of epicardial c-kit (+) cells: role of the pericardial fluid. J Mol Cell Cardiol. 2010;48:609-18. doi: 10.1016/j.yjmcc.2009.11.008 PMID: 19968998
14. Hausser J, Zavolan M. Identification and consequences of miRNA-target interactions-beyond repression of gene expression. Nat Rev Genet. 2014;15:599-612. doi: 10.1038/nrg3765 PMID: 25022902
15. Abdellatif M. Differential expression of microRNAs in different disease states. Circ Res. 2012;110:638-50. doi: 10.1161/CIRCRESAHA.111.247437 PMID: 22343558
16. Elzenaar I, Pinto YM, Van Oort RJ. MicroRNAs in heart failure: new targets in disease management. Clin Pharmacol Ther. 2013;94:480-9. doi: 10.1038/clpt.2013.138 PMID: 23852395
17. Melman YF, Shah R, Das S. MicroRNAs in heart failure: is the picture becoming less miRky? Circ Heart Fail. 2014;7:203-14. doi: 10.1161/CIRCHEARTFAILURE.113.000266 PMID: 24449811
18. Harada M, Luo X, Murohara T, Yang B, Dobrev D, Nattel S. MicroRNA regulation and cardiac calcium signaling: role in cardiac disease and therapeutic potential. Circ Res. 2014;114:689-705. doi: 10. 1161/CIRCRESAHA.114.301798 PMID: 24526675
19. Sluijter JPG, Verhage V, Deddens JC, Van Den Akker F, Doevendans PA. Microvesicles and exosomes for intracardiac communication. Cardiovasc Res. 2014;102:302-11. doi: 10.1093/cvr/cvu022 PMID: 24488559
20. Viereck J, Bang C, Foinquinos A, Thum T. Regulatory RNAs and paracrine networks in the heart. Cardiovasc Res. 2014;102:290-301. doi: 10.1093/cvr/cvu039 PMID: 24562768
21. Sahoo S, Losordo DW. Exosomes and cardiac repair after myocardial infarction. CircRes. 2014;114:333-44. doi: 10.1161/CIRCRESAHA.114.300639 PMID: 24436429
22. Waldenström A, Ronquist G. Role of exosomes in myocardial remodeling. Circ Res. 2014;114:315-24. doi: 10.1161/CIRCRESAHA.114.300584 PMID: 24436427
23. Loyer X, Vion A-C, Tedgui A, Boulanger CM. Microvesicles as cell-cell messengers in cardiovascular diseases. CircRes. 2014;114:345-53. doi: 10.1161/CIRCRESAHA.113.300858 PMID: 24436430
24. Yellon DM, Davidson SM. Exosomes: nanoparticles involved in cardioprotection? Circ Res. 2014;114:325-32. doi: 10.1161/CIRCRESAHA.113.300636 PMID: 24436428
25. Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, et al. The microRNAspectrum in 12 body fluids. Clin Chem. 2010;56:1733-41. doi: 10.1373/clinchem.2010.147405 PMID: 20847327
26. Kamanu TKK, Radovanovic A, Archer JAC, Bajic VB. Exploration of miRNA families for hypotheses generation. Sci Rep. 2013;3:2940. doi: 10.1038/srep02940 PMID: 24126940
27. Sala V, Bergerone S, Gatti S, Gallo S, Ponzetto A, Ponzetto C, et al. MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine. Cell Mol LifeSci. 2014;71:1439-52. doi: 10.1007/s00018-013-1504-0 PMID: 24218009
28. Tijsen AJ, Pinto YM, Creemers EE. Non-cardiomyocyte microRNAs in heart failure. Cardiovasc Res. 2012;93:573-82. doi: 10.1093/cvr/cvr344 PMID: 22180601
29. Brutsaert DL. Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Physiol Rev. 2003;83:59-115. PMID: 12506127
30. Zhou J, Li Y-S, Nguyen P, Wang K-C, Weiss A, Kuo Y-C, et al. Regulation of vascular smooth muscle cell turnover by endothelial cell-secreted microRNA-126: role of shear stress. Circ Res. 2013;113:40-51. doi: 10.1161/CIRCRESAHA.113.280883 PMID: 23603512
31. Hergenreider E, Heydt S, Tréguer K, Boettger T, Horrevoets AJG, Zeiher AM, et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol. 2012;14:249-56. doi: 10.1038/ncb2441 PMID: 22327366
32. Quiat D, Olson EN. MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment. J Clin Invest. 2013;123:11-8. doi: 10.1172/JCI62876 PMID: 23281405
33. Barile L, Lionetti V, Cervio E, Matteucci M, Gherghiceanu M, Popescu LM, et al. Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction. Cardiovasc Res. 2014;
34. Bang C, Batkai S, Dangwal S, Gupta SK, Foinquinos A, Holzmann A, et al. Cardiacfibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J Clin Invest. 2014;124:2136-46. doi: 10.1172/JCI70577 PMID: 24743145
35. Ben-Horin S, Shinfeld A, Kachel E, Chetrit A, Livneh A. The composition of normal pericardial fluid and its implications for diagnosing pericardial effusions. Am J Med. 2005;118:636-40. PMID: 15922695
36. Pritchard CC, Kroh E, Wood B, Arroyo JD, Dougherty KJ, Miyaji MM, et al. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res (Phila). 2012;5:492-7. doi: 10.1158/1940-6207. CAPR-11-0370 PMID: 22158052
37. Tijsen AJ, Creemers EE, Moerland PD, De Windt LJ, Van Der Wal AC, Kok WE, et al. MiR423-5pasa circulating biomarker for heart failure. Circ Res. 2010;106:1035-9. doi: 10.1161/CIRCRESAHA.110. 218297 PMID: 20185794
38. Goren Y, Kushnir M, Zafrir B, Tabak S, Lewis BS, Amir O. Serum levels of microRNAs in patients with heart failure. Eur J Heart Fail. 2012;14:147-54. doi: 10.1093/eurjhf/hfr155 PMID: 22120965
39. Dickinson BA, Semus HM, Montgomery RL, Stack C, Latimer PA, Lewton SM, et al. Plasma micro-RNAs serve as biomarkers of therapeutic efficacy and disease progression in hypertension-induced heart failure. Eur J Heart Fail. 2013;15:650-9. doi: 10.1093/eurjhf/hft018 PMID: 23388090
40. Fan K-L, Zhang H-F, Shen J, Zhang Q, Li X-L. Circulating microRNAs levels in Chinese heart failure patients caused by dilated cardiomyopathy. Indian Heart J. 65:12-6. doi: 10.1016/j.ihj.2012.12.022 PMID: 23438607
41. Goldraich LA, Martinelli NC, Matte U, Cohen C, Andrades M, Pimentel M, et al. Transcoronary gradient of plasma microRNA 423-5p in heart failure: evidence of altered myocardial expression. Biomarkers. 2014;19:135-41. doi: 10.3109/1354750X.2013.870605 PMID: 24506564
42. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA. 2008;105:10513-8. doi: 10.1073/pnas.0804549105 PMID: 18663219
43. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18:997-1006. doi: 10. 1038/cr.2008.282 PMID: 18766170
44. Kirby TJ, McCarthy JJ. MicroRNAs in skeletal muscle biology and exercise adaptation. Free RadicBiol Med. 2013;64:95-105. doi: 10.1016/j.freeradbiomed.2013.07.004 PMID: 23872025
45. Lai CTM, Ng EKO, Chow P, Kwong A, Cheung Y. Circulating microRNA expression profile and systemic right ventricular function in adults after atrial switch operation for complete transposition of the great arteries. BMC Cardiovasc Disord. 2013;13:73. doi: 10.1186/1471-2261-13-73 PMID: 24040857
46. Faraonio R, Salerno P, Passaro F, Sedia C, Iaccio A, Bellelli R, et al. A set of miRNAs participates in the cellular senescence program in human diploid fibroblasts. Cell Death Differ. 2012;19:713-21. doi: 10.1038/cdd.2011.143 PMID: 22052189
47. Cheng Y, Zhang C. MicroRNA-21 in cardiovascular disease. J Cardiovasc Transl Res. 2010;3:251-5. doi: 10.1007/s12265-010-9169-7 PMID: 20560046
48. Kumarswamy R, Thum T. Non-coding RNAs in cardiac remodeling and heart failure. Circ Res. 2013;113:676-89. doi: 10.1161/CIRCRESAHA.113.300226 PMID: 23989712
49. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature. 2008;456:980-4. doi: 10. 1038/nature07511 PMID: 19043405
50. Cardin S, Guasch E, Luo X, Naud P, Le Quang K, Shi Y, et al. Role for MicroRNA-21 in atrial profibrillatory fibrotic remodeling associated with experimental postinfarction heart failure. Circ Arrhythm Electrophysiol. 2012;5:1027-35. doi: 10.1161/CIRCEP.112.973214 PMID: 22923342
51. Adam O, Löhfelm B, Thum T, Gupta SK, Puhl S-L, Schäfers H-J, et al. Role of miR-21 in the pathogenesis of atrial fibrosis. Basic Res Cardiol. 2012;107:278. doi: 10.1007/s00395-012-0278-0 PMID: 22760500
52. Liu G, Friggeri A, Yang Y, Milosevic J, Ding Q, Thannickal VJ, et al. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med. 2010;207:1589-97. doi: 10.1084/jem. 20100035 PMID: 20643828
53. Chau BN, Xin C, Hartner J, Ren S, Castano AP, Linn G, et al. MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways. SciTransl Med. 2012;4:121ra18.
54. Zhong X, Chung ACK, Chen H-Y, Meng X-M, Lan HY. Smad3-mediated upregulation of miR-21 promotes renal fibrosis. J AmSoc Nephrol. 2011;22:1668-81. doi: 10.1681/ASN.2010111168 PMID: 21852586
55. Ardite E, Perdiguero E, Vidal B, Gutarra S, Serrano AL, Muñoz-Cánoves P. PAI-1-regulated miR-21 defines a novel age-associated fibrogenic pathway in muscular dystrophy. J Cell Biol. 2012;196:163-75. doi: 10.1083/jcb.201105013 PMID: 22213800
56. Chen L, Wang Y, Pan Y, Zhang L, Shen C, Qin G, et al. Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia/reperfusion injury. Biochem Biophys ResCommun. 2013;431:566-71. doi: 10.1016/j.bbrc.2013.01.015 PMID: 23318173
57. Wang X, Zhu H, Zhang X, Liu Y, Chen J, Medvedovic M, et al. Loss of the miR-144/451 cluster impairs ischaemic preconditioning-mediated cardioprotection by targeting Rac-1. Cardiovasc Res. 2012;94:379-90. doi: 10.1093/cvr/cvs096 PMID: 22354898
58. Zhang X, Wang X, Zhu H, Zhu C, Wang Y, Pu WT, et al. Synergistic effects of the GATA-4-mediated miR-144/451 cluster in protection against simulated ischemia/reperfusion-induced cardiomyocyte death. J Mol Cell Cardiol. 2010;49:841-50. doi: 10.1016/j.yjmcc.2010.08.007 PMID: 20708014
59. Bostjancic E, Zidar N, Glavac D. MicroRNA microarray expression profiling in human myocardial infarction. Dis Markers. 2009;27:255-68. doi: 10.3233/DMA-2009-0671 PMID: 20075508
60. Ren J, Zhang J, Xu N, Han G, Geng Q, Song J, et al. Signature of circulating microRNAsas potential biomarkers in vulnerable coronary artery disease. PLoSOne. 2013;8:e80738. doi: 10.1371/journal. pone.0080738 PMID: 24339880
61. Huang S, Chen M, Li L, He M, Hu D, Zhang X, et al. Circulating MicroRNAs and the Occurrence of Acute Myocardial Infarction in Chinese Populations. Circ Cardiovasc Genet. 2014;7:189-98. doi: 10. 1161/CIRCGENETICS.113.000294 PMID: 24627568
62. Voellenkle C, Van Rooij J, Cappuzzello C, Greco S, Arcelli D, Di Vito L, et al. MicroRNA signatures in peripheral blood mononuclear cells of chronic heart failure patients. Physiol Genomics. 2010;42:420-6. doi: 10.1152/physiolgenomics.00211.2009 PMID: 20484156
63. Vacchi-Suzzi C, Hahne F, Scheubel P, Marcellin M, Dubost V, Westphal M, et al. Heart structure-specific transcriptomic atlas reveals conserved microRNA-mRNA interactions. PLoSOne. 2013;8:e52442. doi: 10.1371/journal.pone.0052442 PMID: 23300973
64. Wang X, Ha T, Zou J, Ren D, Liu L, Zhang X, et al. MicroRNA-125b protects against myocardial ischaemia/reperfusion injury via targeting p53-mediated apoptotic signalling and TRAF6. Cardiovasc Res. 2014;102:385-95. doi: 10.1093/cvr/cvu044 PMID: 24576954
65. Bao M-H, Feng X, Zhang Y-W, Lou X-Y, Cheng Y, Zhou H-H. Let-7 in cardiovascular diseases, heart development and cardiovascular differentiation from stem cells. Int J Mol Sci. 2013;14:23086-102. doi: 10.3390/ijms141123086 PMID: 24284400
66. Long G, Wang F, Duan Q, Yang S, Chen F, Gong W, et al. Circulating miR-30a, miR-195and let-7b associated with acute myocardial infarction. PLoSOne. 2012;7:e50926. doi: 10.1371/journal.pone. 0050926 PMID: 23236408
67. Long G, Wang F, Li H, Yin Z, Sandip C, Lou Y, et al. Circulating miR-30a, miR-126andlet-7bas biomarker for ischemic stroke in humans. BMC Neurol. 2013;13:178. doi: 10.1186/1471-2377-13-178 PMID: 24237608
68. Gidlöf O, Vander Brug M, Ohman J, Gilje P, Olde B, Wahlestedt C, et al. Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression. Blood. 2013;121:3908-17, S1-26. doi: 10.1182/blood-2012-10-461798 PMID: 23493781
69. Lv P, Zhou M, He J, Meng W, Ma X, Dong S, et al. Circulating miR-208b and miR-34a are associated with left ventricular remodeling after acute myocardial infarction. Int J Mol Sci. 2014;15:5774-88. doi: 10.3390/ijms15045774 PMID: 24714087
70. Li Z, Lu J, Luo Y, Li S, Chen M. High association between human circulating microRNA-497 and acute myocardial infarction. ScientificWorldJournal. 2014;2014:931845. doi: 10.1155/2014/931845 PMID: 25110754
71. Shan Z, Yao C, Li Z, Teng Y, Li W, Wang J, et al. Differentially expressed microRNAs at different stages of atherosclerosis in ApoE-deficientmice. Chin Med J (Engl). 2013;126:515-20. PMID: 23422117
72. Bidzhekov K, Gan L, Denecke B, Rostalsky A, Hristov M, Koeppel TA, et al. microRNA expression signatures and parallels between monocyte subsets and atherosclerotic plaque in humans. Thromb Haemost. 2012;107:619-25. doi: 10.1160/TH11-09-0607 PMID: 22370758
73. Emanueli C, Thum T. miRNAGE-34 induces cardiac damAGE. Cell Res. 2013;23:866-7. doi: 10. 1038/cr.2013.57 PMID: 23609795
74. Boon RA, Iekushi K, Lechner S, Seeger T, Fischer A, Heydt S, et al. MicroRNA-34a regulates cardiac ageing and function. Nature. 2013;495:107-10. doi: 10.1038/nature11919 PMID: 23426265
75. Kane NM, Howard L, Descamps B, Meloni M, McClure J, Lu R, et al. Role of microRNAs 99b, 181a, and 181b in the differentiation of human embryonic stem cells to vascular endothelial cells. Stem Cells. 2012;30:643-54. doi: 10.1002/stem.1026 PMID: 22232059
76. McCall MN, Kent OA, Yu J, Fox-Talbot K, Zaiman AL, Halushka MK. MicroRNA profiling of diverse endothelial cell types. BMC Med Genomics. 2011;4:78. doi: 10.1186/1755-8794-4-78 PMID: 22047531
77. Condorelli G, Latronico MVG, Cavarretta E. microRNAs in cardiovascular diseases: current knowledge and the road ahead. J Am Coll Cardiol. 2014;63:2177-87. doi: 10.1016/j.jacc.2014.01.050 PMID: 24583309
78. Yang K-C, Yamada KA, Patel AY, Topkara VK, George I, Cheema FH, et al. Deep RNAsequencing reveals dynamic regulation of myocardial noncoding RNAs in failing human heart and remodeling with mechanical circulatory support. Circulation. 2014;129:1009-21. doi: 10.1161/CIRCULATIONAHA. 113.003863 PMID: 24429688